Published in J Exp Med on January 01, 1975
Modulation of lymphocyte mitogenesis. Proc Natl Acad Sci U S A (1975) 2.02
Inhibition of lymphocyte mitogenesis by immobilized antigen-antibody complexes. J Exp Med (1975) 1.55
Regulation of guanylate and adenylate cyclase activities by lysolecithin. Proc Natl Acad Sci U S A (1976) 1.50
Alteration of cellular adhesion by nerve growth factor. Proc Natl Acad Sci U S A (1977) 1.50
Immunocompetent cells in resistance to bacterial infections. Bacteriol Rev (1976) 1.31
Mechanisms of macrophage activation. Clin Exp Immunol (1980) 1.25
Fc receptor-mediated inhibition of murine B-lymphocyte activation. J Exp Med (1976) 1.05
The content and metabolism of cyclic adenosine 3', 5'-monophosphate and cyclic guanosine 3', 5'-monophosphate in adenocarcinoma of the human colon. J Clin Invest (1976) 1.05
Fibronectin binding to complement subcomponent C1q. Localization of their respective binding sites. Biochem J (1985) 0.96
Cyclic guanosine 3',5'-monophosphate in the dimorphic fungus Mucor racemosus. J Bacteriol (1976) 0.90
Effects of concanavalin A and a succinylated derivative on lymphocyte proliferation and cyclic nucleotide levels. Proc Natl Acad Sci U S A (1976) 0.90
Lung cancer: a classic example of tumor escape and progression while providing opportunities for immunological intervention. Clin Dev Immunol (2012) 0.89
Two distinct lumphocyte-stimulating soluble factors (LAF) released from murine peritoneal cells. I. The cellular source and the effect of cGMP on their release. Immunology (1976) 0.87
Activation of lymphocytes by brominated nucleoside and cyclic nucleotide analogues: implications for the "second messenger" function of cyclic GMP. Proc Natl Acad Sci U S A (1981) 0.84
Circulating immunoreactive and bioassayable opsonic plasma fibronectin during experimental tumour growth. Br J Cancer (1980) 0.79
Impaired antibody responses in alloxan diabetic mice. Clin Exp Immunol (1977) 0.78
Patterns of cyclic nucleotides in normal and leukaemic human leucocytes. Br J Cancer (1980) 0.77
Intercellular immunological controls and modulation of cyclic AMP levels. Some doubts. Immunology (1976) 0.77
Long-term growth of lines of murine dinitrophenyl-specific B lymphocytes in vitro. J Exp Med (1983) 0.77
IL-6-mediated MHC class II induction on RIN-5AH insulinoma cells by IFN-gamma occurs via the G-protein pathway. Mediators Inflamm (1995) 0.75
Lobenzarit disodium inhibits the constitutive NO-cGMP metabolic pathways. Possible involvement as an immunomodulatory drug. Mediators Inflamm (1995) 0.75
Intracellular contents of cyclic nucleotides in neutrophils and lymphocytes from patients with systemic lupus erythematosus. Arch Dermatol Res (1989) 0.75
Phenotypic transformation of clonal myogenic cells to cells resembling chondrocytes. Proc Natl Acad Sci U S A (1976) 0.75
Low beta-adrenergic receptor concentration on human thymocytes. Clin Exp Immunol (1983) 0.75
Antitrinitrophenyl (TNP) plaque assay. Primary response of Balb/c mice to soluble and particulate immunogen. Proc Soc Exp Biol Med (1969) 18.89
Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. J Biol Chem (1972) 8.24
A theory of self-nonself discrimination. Science (1970) 7.99
The behavior of hapten-poly-L-lysine conjugates as complete antigens in genetic responder and as haptens in nonresponder guinea pigs. J Exp Med (1966) 4.58
Carrier function in anti-hapten antibody responses. 3. Stimulation of antibody synthesis and facilitation of hapten-specific secondary antibody responses by graft-versus-host reactions. J Exp Med (1971) 4.29
Guanosine 3':5'-cyclic monophosphate: a possible intracellular mediator of mitogenic influences in lymphocytes. Proc Natl Acad Sci U S A (1972) 3.65
Differentiation of T cells induced by preparations from thymus and by nonthymic agents. J Exp Med (1973) 3.12
Growth control and cyclic alterations of cyclic AMP in the cell cycle. Nat New Biol (1972) 2.93
Difference in the cyclic adenosine 3',5'-monophosphate levels in normal and transformed cells. Nat New Biol (1972) 2.90
Regulation of cell growth by cyclic adenosine 3',5'-monophosphate. Effect of cell density and agents which alter cell growth on cyclic adenosine 3',5'-monophosphate levels in fibroblasts. J Biol Chem (1972) 2.85
Lymphocyte blast transformation. I. Demonstration of adrenergic receptors in human peripheral lymphocytes. Cell Immunol (1970) 2.58
The use of bacterial lipopolysaccharides to show that two signals are required for the induction of antibody synthesis. J Exp Med (1973) 2.30
Termination of tolerance to human gamma globulin in mice by antigen and bacterial lipopolysaccharide (endotoxin). J Exp Med (1973) 2.15
Mechanism of thymus-independent immunocyte triggering. Mitogenic activation of B cells results in specific immune responses. J Exp Med (1974) 2.04
Nonantigenicity and immunologic tolerance: the role of the carrier in the induction of tolerance to the hapten. J Exp Med (1971) 2.02
Possible involvement of cyclic GMP in growth control of cultured mouse cells. Nature (1974) 1.96
Immune response to a hapten coupled to a nonimmunogenic carrier. Influence of lipopolysaccharide. J Exp Med (1972) 1.95
The role of humoral factors in the initiation of in vitro primary immune responses. II. Effects of lymphocyte mitogens. J Immunol (1973) 1.90
B cell mitogenic properties of thymus-independent antigens. Nat New Biol (1973) 1.80
Hapten-specific tolerance: unresponsiveness in the T cell-depleted population. Eur J Immunol (1973) 1.47
Cyclic nucleotides as intracellular mediators of the expression of antigen-sensitive cells. Nature (1973) 1.39
Immunity tolerance to a hapten (NIP) coupled to an isologous carrier (mouse gamma globulin). J Exp Med (1972) 1.18
Immunological tolerance in bone marrow-derived lymphocytes. 3. Tolerance induction in primed B cells by hapten conjugates of unrelated immunogenic or "nonimmunogenic" carriers. J Exp Med (1974) 1.17
N 6 ,O 2 '-dibutyryl adenosine 3',5'-monophosphate induces pigment production in melanoma cells. Nat New Biol (1972) 1.15
Role of cyclic adenosine 3',5'-monophosphate in lymphocyte mitogenesis. J Immunol (1974) 0.98
Contact inhibition of transformed cells incompletely restored by dibutyryl cyclic AMP. Nat New Biol (1972) 0.92
The use of allogeneic T lymphocytes and bacterial lipopolysaccharide to induce immune responses to monovalent haptens in vitro. J Immunol (1974) 0.91
Enhancement by purine nucleosides and nucleotides of serum-induced DNA synthesis in quiescent 3T3 cells. J Cell Physiol (1973) 0.90
Induction of a primary antihapten response in vivo by a graft-vs.-host reaction. J Exp Med (1973) 0.81
Lymphocyte stimulation by cyclic AMP, GMP and related compounds. 1. Proc Soc Exp Biol Med (1972) 0.78
Meta-analysis of theory-of-mind development: the truth about false belief. Child Dev (2001) 11.06
Continuous proliferation of murine antigen-specific helper T lymphocytes in culture. J Exp Med (1979) 7.20
Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines. J Exp Med (1979) 5.22
Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic respones to lipopolysaccharides. J Exp Med (1974) 4.48
Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line. J Exp Med (1980) 4.32
Systematic implementation of an advance directive program in nursing homes: a randomized controlled trial. JAMA (2000) 3.87
ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev (1999) 3.45
Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines. J Immunol (1980) 3.28
Generic inhalers for asthma. BMJ (1994) 3.09
ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation. J Cell Sci (1998) 2.83
Molecular and quantitative analysis of helper T cell-replacing factors on the induction of antigen-sensitive B and T lymphocytes. J Immunol (1979) 2.79
Immune response to Campylobacter pyloridis in patients with peptic ulceration. Lancet (1985) 2.64
Young people, alcohol, and designer drinks: quantitative and qualitative study. BMJ (1997) 2.64
HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol (2000) 2.60
Evidence for two distinct classes of murine B cell growth factors with activities in different functional assays. J Exp Med (1983) 2.56
The genetic mapping of a defective LPS response gene in C3H/HeJ mice. J Immunol (1978) 2.43
The use of bacterial lipopolysaccharides to show that two signals are required for the induction of antibody synthesis. J Exp Med (1973) 2.30
Enteroaggregative Escherichia coli heat-stable enterotoxin 1 represents another subfamily of E. coli heat-stable toxin. Proc Natl Acad Sci U S A (1993) 2.28
Interleukin 2: a class of T cell growth factors. Immunol Rev (1980) 2.21
Performance of an established system of first responder out-of-hospital defibrillation. The results of the second year of the Heartstart Scotland Project in the 'Utstein Style'. Resuscitation (1993) 2.17
An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital. J Hosp Infect (1998) 2.10
Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. Ann Rheum Dis (1993) 2.05
The purification and quantitation of helper T cell-replacing factors secreted by murine spleen cells activated by concanavalin A. J Immunol (1979) 1.95
The role of humoral factors in the initiation of in vitro primary immune responses. II. Effects of lymphocyte mitogens. J Immunol (1973) 1.90
Research Governance: a barrier to ethical research? QJM (2004) 1.89
Disease progression in a cohort of infants with vertically acquired HIV infection observed from birth: the Women and Infants Transmission Study (WITS). J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.88
Biochemical and biologic characterization of lymphocyte regulatory molecules. III. The isolation and phenotypic characterization of Interleukin-2 producing T cell lymphomas. J Immunol (1980) 1.79
A survey of zoonotic pathogens carried by Norway rats in Baltimore, Maryland, USA. Epidemiol Infect (2007) 1.73
Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. J Hepatol (1996) 1.73
Enteroaggregative Escherichia coli heat-stable enterotoxin is not restricted to enteroaggregative E. coli. J Infect Dis (1996) 1.69
The response of recombinant inbred strains of mice to bacterial lipopolysaccharides. J Immunol (1977) 1.64
c-myc oncogene expression in colorectal cancer. Cancer (1987) 1.60
Analysis of Photosynthetic Antenna Function in a Mutant of Arabidopsis thaliana (L.) Lacking trans-Hexadecenoic Acid. Plant Physiol (1985) 1.60
Efficacy of out of hospital defibrillation by ambulance technicians using automated external defibrillators. The Heartstart Scotland Project. Resuscitation (1992) 1.60
Helper T cell-replacing factors secreted by thymus-derived cells and macrophages: cellular requirements for B cell activation and synergistic properties. J Immunol (1979) 1.59
Anesthesia for intranasal surgery: a comparison between tracheal intubation and the flexible reinforced laryngeal mask airway. Anesth Analg (1999) 1.59
Effectiveness of antismoking telephone helpline: follow up survey. BMJ (1997) 1.58
The role of humoral factors in the initiation of in vitro primary immune responses. 3. Characterization of factors that replace thymus-derived cells. J Immunol (1973) 1.55
Increased detection of Mycoplasma pneumoniae infection in children in England and Wales, October 2011 to January 2012. Euro Surveill (2012) 1.51
Toward a caring curriculum: a new pedagogy for nursing. NLN Publ (1989) 1.49
Gastroparesis with multiple sclerosis. Mult Scler (2006) 1.48
Detection of the c-myc oncogene product in colonic polyps and carcinomas. Br J Cancer (1986) 1.47
Interleukin-2 dependent culture of cytolytic T cell lines. Immunol Rev (1981) 1.46
On nursing theories and evidence. J Nurs Scholarsh (2001) 1.46
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44
Personal experience with ultrasound-assisted lipoplasty: a pilot study comparing ultrasound-assisted lipoplasty with traditional lipoplasty. Plast Reconstr Surg (1998) 1.41
Leukemia viruses associated with mouse myeloma cells. Proc Natl Acad Sci U S A (1970) 1.40
Reflections on the recommendations of the EWMA Patient Outcome Group document. J Wound Care (2010) 1.39
Cyclic nucleotides as intracellular mediators of the expression of antigen-sensitive cells. Nature (1973) 1.39
Cumulation characteristics of cisatracurium and rocuronium during continuous infusion. Can J Anaesth (2000) 1.39
[Not Available]. Praxis (Bern 1994) (2011) 1.38
Alcohol use among migrant laborers in western New York. J Stud Alcohol (1985) 1.37
The integrated implementation of two end-of-life care tools in nursing care homes in the UK: an in-depth evaluation. Palliat Med (2010) 1.35
Genetic control of responses to Trypanosoma cruzi in mice: multiple genes influencing parasitemia and survival. Infect Immun (1982) 1.34
Immunologic properties of bacterial lipopolysaccharide (LPS). III. Genetic linkage between the in vitro mitogenic and in vivo adjuvant properties of LPS. J Exp Med (1976) 1.34
Isolation of an Hfr donor of Pseudomonas aeruginosa PAO by insertion of the plasmid RP1 into the tryptophan synthase gene. Mol Gen Genet (1981) 1.32
Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1. Br J Pharmacol (2008) 1.32
Evidence for validity of a health status measure in assessing short term outcomes of cholecystectomy. Qual Health Care (1992) 1.26
The economic burden of schizophrenia in Canada. Can J Psychiatry (1999) 1.25
Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors. Blood (1996) 1.24
Oncogenic transformation of murine lymphoid cells by in vitro infection with Abelson leukemia virus. J Natl Cancer Inst (1975) 1.24
Genetic control of endotoxic responses in mice. J Exp Med (1978) 1.24
Sexual dysfunction in primary medical care: prevalence, characteristics and detection by the general practitioner. J Public Health Med (1997) 1.20
Clinical utility of monitoring serum cryptococcal antigen (sCRAG) titers in patients with AIDS-related cryptococcal disease. HIV Clin Trials (2001) 1.19
Regulation of the human fas promoter by YB-1, Puralpha and AP-1 transcription factors. Gene (2000) 1.17
Genetic control of the immune response to collagen. II. Antibody responses produced in fetal liver restored radiation chimeras and thymus reconstituted F1 hybrid nude mice. J Exp Med (1979) 1.15
Effect of a synthetic adjuvant on the induction of primary immune responses in T cell-depleted spleen cultures. J Immunol (1978) 1.13
The causative rhythm in out-of-hospital cardiac arrests witnessed by the emergency medical services in the Heartstart Scotland Project. Resuscitation (1994) 1.11
Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up. Clin Exp Immunol (1997) 1.11
Biochemical and biologic characterization of lymphocyte regulatory molecules. IV. Purification of Interleukin 2 from a murine T cell lymphoma. J Immunol (1980) 1.11
Some cytofluorimetric studies of the nuclear ploidy of mouse hepatocytes. I. A simple method for isolation of hepatocyte nuclei using in situ perfusion of the liver. Br J Exp Pathol (1981) 1.10
Suppressive effects of visual and facial screening on self-injurious finger-sucking. Am J Ment Defic (1986) 1.10
The first identified case of pandemic H1N1 influenza in pigs in Australia. Aust Vet J (2011) 1.09
Epidural analgesia during labour. CMAJ (1993) 1.08
Production and characterisation of monoclonal and polyclonal antibodies to different regions of the cystic fibrosis transmembrane conductance regulator (CFTR): detection of immunologically related proteins. J Cell Sci (1995) 1.06
Four years' experience at a specialised burns centre. The McIndoe Burns Centre 1965-68. Lancet (1969) 1.05
Out-patient parenteral antimicrobial therapy--a viable option for the management of cutaneous leishmaniasis. QJM (1999) 1.04
New world mucosal and cutaneous leishmaniasis: an emerging health problem among British travellers. QJM (2004) 1.04
Fetoscopy in the assessment of unexplained fetal hydrops. Br J Obstet Gynaecol (1985) 1.03
The origin of the long-wavelength fluorescence emission band (77 degrees K) from photosystem I. Arch Biochem Biophys (1984) 1.03
A comparison of depression and styles of coping in male and female GA members and controls. J Gambl Stud (2000) 1.02
Prevalence of nifedipine-induced gingival hyperplasia. J Periodontol (1995) 1.02
The role of humoral factors in the initiation of in vitro primary immune responses. I. Effects of deficient fetal bovine serum. J Immunol (1973) 1.02
The interaction of Herpes Simplex Virus with murine lymphocytes. I. Mitogenic properties of herpes simplex virus. J Exp Med (1977) 1.01
A pseudo outbreak of tuberculosis. Commun Dis Rep CDR Rev (1994) 1.01
Non-invasive treatment of ununited fractures of the tibia using electrical stimulation. J Bone Joint Surg Br (1980) 1.00
A compact linac for intensity modulated proton therapy based on a dielectric wall accelerator. Phys Med (2008) 1.00
Some flow cytofluorimetric studies of the nuclear ploidy of mouse hepatocytes. II. Early changes in nuclear ploidy of mouse hepatocytes following carbon tetrachloride administration: evidence for polyploid nuclei arrested in telophase. Br J Exp Pathol (1981) 1.00
SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity. Br J Pharmacol (1998) 0.97
Electrocardiographic ST-segment changes during acute, severe isovolemic hemodilution in humans. Anesthesiology (2000) 0.97
A survey of rodent-borne pathogens carried by wild-caught Norway rats: a potential threat to laboratory rodent colonies. Lab Anim (2008) 0.97
Signalling pathways regulating the dephosphorylation of Ser729 in the hydrophobic domain of protein kinase Cepsilon upon cell passage. J Biol Chem (2000) 0.97
The involvement of cyclic nucleotide metabolism in the initiation of lymphocyte proliferation induced by mitogens. J Immunol (1976) 0.96
Expression of the Wilms' tumour gene WT1 in the developing human and in paediatric renal tumours: an immunohistochemical study. Mol Pathol (1997) 0.96
Nursing: human science and human care. A theory of nursing. NLN Publ (1988) 0.95
Effect of cardiogenic oscillations on gas mixing during tracheal insufflation of oxygen. J Appl Physiol (1985) (1986) 0.94